{
  "retracted": false,
  "timestamp": 1541030400000,
  "updates": [
    {
      "timestamp": 1592007091194,
      "identifier": {
        "doi": "10.1158/1078-0432.ccr-18-3193"
      },
      "type": "correction"
    }
  ],
  "identifier": {
    "doi": "10.1158/1078-0432.ccr-17-0754"
  },
  "publisher": "American Association for Cancer Research (AACR)",
  "title": "Correction: MONARCH 1, A Phase II Study of Abemaciclib, a CDK4 and CDK6 Inhibitor, as a Single Agent, in Patients with Refractory HR+/HER2âˆ’ Metastatic Breast Cancer"
}
